|
|
What is MVI?The PATH Malaria Vaccine Initiative is a focused vaccine development program created in 1999 through a grant from the Bill & Melinda Gates Foundation. PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH’s work improves global health and well-being. MVI's mission is to accelerate the development of promising malaria vaccines and ensure their availability and accessibility in the developing world. To accomplish the first part of its mission, MVI is identifying the most promising vaccines and technologies and implementing targeted partnerships with scientists, vaccinologists, and development projects. MVI works to link government, industry, and academia partners with field trial sites in malaria endemic countries as early as feasible in the development process. To help ensure access to the eventual vaccine(s), MVI works with other vaccine programs, vaccine development partners, and the Global Alliance for Vaccines and Immunization (GAVI) to explore commercialization, procurement, and delivery strategies that will maximize public health sector availability in the countries most affected by malaria. |
